Product Information

OXYMORPHONE HCL 10 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.2245 per EA under NDC 31722093001. Its NADAC has been published 400 times since Jun 20, 2018.

FDA first approved this application on Feb 2, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXYMORPHONE HCL 10 MG TABLET

OXYMORPHONE HYDROCHLORIDE
$1.2245per EA
DEA Schedule CII

Strength

10 mg/1

NDC

31722093001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

5/21/2025

Active Ingredients

OXYMORPHONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210175

FDA Approved

2/2/2018

TE Code

AB

On Market Since

3/1/2018

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for OXYMORPHONE HCL 10 MG TABLET has been published 400 times since Jun 20, 2018, and over the history we have for it it has declined 22.1%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2245 per EA
All-time high$1.7127 (Sep 11, 2024)
All-time low$0.2729 (Jul 21, 2021)
52-week high$1.2245
52-week low$1.2245
Median price$1.1015
Average price$1.0481
Largest weekly change+182.1% (Feb 21, 2024)
Weeks tracked400
Tracking sinceJun 20, 2018

Price History

1W

N/A

1M

N/A

3M

N/A

6M

0.0%

1Y

0.0%

3Y

+128.2%

5Y

+183.3%

All

-22.1%

Last surveyed May 13, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OXYMORPHONE HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of OXYMORPHONE HCL 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXYMORPHONE HCL 10 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.2245 per EA (NDC 31722093001), effective May 13, 2026.

How has the price of OXYMORPHONE HCL 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXYMORPHONE HCL 10 MG TABLET has declined 22.1%. It has been tracked across 400 weekly CMS publications since Jun 20, 2018.

What are the highest and lowest recorded NADAC prices for OXYMORPHONE HCL 10 MG TABLET?

Since Jun 20, 2018, the NADAC for OXYMORPHONE HCL 10 MG TABLET has ranged from a low of $0.2729 (Jul 21, 2021) to a high of $1.7127 (Sep 11, 2024), with a median of $1.1015 per EA.

Are there cheaper alternatives to OXYMORPHONE HCL 10 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of OXYMORPHONE HCL 10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OXYMORPHONE HCL 10 MG TABLET?

OXYMORPHONE HCL 10 MG TABLET (NDC 31722093001) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.